Insights on Leveraging AI in Biopharmaceutical R&D: A Discussion with Kailash Swarna Last month, Accenture released a report titled “Reinventing R&D in the Age of AI,” which explores how biopharmaceutical companies can harness artificial intelligence (AI) and other advanced technologies to enhance drug and therapeutic research and development. AI in Drug Research. Kailash Swarna, managing